Thermo Fisher Scientific (NYSE:TMO) announced today that it completed its previously announced $17.4 billion acquisition of PPD. Waltham, Massachusetts-based Thermo Fisher announced in April that it would acquire the company that provides clinical research services to the biopharma and biotech industry. PPD ceased trading on the Nasdaq prior to opening today and will become part of […]
PPD Inc.
Thermo Fisher to buy PPD for $17B
Thermo Fisher Scientific (NYSE:TMO) announced today that it agreed to acquire PPD (NSDQ:PPD) for $17.4 billion. The boards of directors for both companies approved the definitive agreement, which will see Thermo Fisher buy PPD for $47.50 per share, totaling $17.4 billion, plus the assumption of approximately $3.5 billion of net debt, according to a news […]
Simbionix buys GMV’s Arthro VR training simulator | Deals Roundup
Simbionix USA Corp. acquired the Arthro VR arthroscopic training simulator line from Spain’s GMV for an undisclosed amount.
The deal broadens Simbionix’s footprint in the orthopedic training arena. The Arthro VR features a line of simulated procedures using fiberglass limb replicas, 3D images and haptic sensation.
Whistleblowing doctor fired from Northwestern University | Personnel Moves
A Northwestern University cardiologist who sparked a federal investigation into a fellow physician for alleged misconduct was fired after being denied tenure.
Dr. Nalini Rajamannan, who was an associate professor of medicine at the university, believes she was fired for providing evidence to federal investigators and for challenging the university’s star surgeon.
Intrinsic Therapeutics puts a new man in charge | Personnel Moves
Intrinsic Therapeutics named Wright Medical (NSQD:WMGI) veteran Cary Hagan as its new President & CEO. Greg Lambrect, founder of Intrinsic will stay on as executive director.
"Cary’s proven success in bringing new technologies to the global market makes him an ideal choice to lead Intrinsic’s next stage of growth as we expand our international clinical and commercial activity," said Lambrecht in prepared remarks.
PPD appoints Raymond Hill as CEO
WILMINGTON, N.C.–(BUSINESS WIRE)–PPD, Inc. (Nasdaq: PPDI) today announced that its board of directors has named Raymond H. Hill as PPD’s new chief executive officer and elected him to the board of directors, both effective September 16.
BD profits increase 5 percent on sales growth | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
PPD CEO David Grange to retire | Personnel moves
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more news on recent hirings and firings in the industry, check out MassDevice’s compilation of the latest personnel moves.
PPD Inc.’s Q4 sales and earnings slide
PPD Inc. (NSDQ:PPDI) posted fourth-quarter sales of $357.4 million for the three months ended Dec. 31, 2009, down 1.6 percent compared with $363.1 million during the same period last year. Net income fell 59.8 percent to $19 million, compared with $47.2 million during Q4 2008:
Press Release
PPD Reports Fourth Quarter and Full Year 2009 Financial Results
Highlights: